Evista 60 by Daiichi Sankyo is a medication containing raloxifene hydrochloride, a selective estrogen receptor modulator (SERM). It is primarily used for the treatment and prevention of osteoporosis in postmenopausal women. Evista works by inhibiting bone resorption, which helps maintain bone density and reduce the risk of fractures, particularly vertebral fractures.